Literature DB >> 10216216

p53 mutations in tumors derived from irradiated human thyroid epithelial cells.

S C Gamble1, M C Cook, A C Riches, Z Herceg, P E Bryant, J E Arrand.   

Abstract

A non-tumorigenic human thyroid epithelial cell line (HTori-3) has been transformed into tumorigenic cells by exposure in vitro to alpha particles or gamma-radiation. These transformants were tumorigenic in athymic nude mice and tumors were transplantable into other nude mice. To further characterize processes involved in neoplastic progression, the tumor cell lines derived from these radiation-induced primary tumors were screened for mutations in the p53 tumor suppressor gene. p53 mutation was detected by single-strand conformation polymorphism (SSCP) analysis of exons 5 to 8 inclusive. Mutations detected by SSCP analysis were confirmed by sequencing. Mutations were detected in all four exons analysed, although there was no correlation between dose, LET or mutation position or frequency. Mutations in p53 exons 6 and 7 have been reported in the childhood papillary thyroid carcinomas in Belarus presumably as a result of radioiodine fall-out. Similarly here, p53 mutations are induced experimentally during the development of human thyroid tumors generated by irradiation of a human thyroid epithelial cell line in vitro. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10216216     DOI: 10.1016/s0027-5107(99)00045-7

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  3 in total

Review 1.  P53 mutations in thyroid carcinoma: tidings from an old foe.

Authors:  N R Farid
Journal:  J Endocrinol Invest       Date:  2001 Jul-Aug       Impact factor: 4.256

Review 2.  Radiation and Thyroid Cancer.

Authors:  Elisabetta Albi; Samuela Cataldi; Andrea Lazzarini; Michela Codini; Tommaso Beccari; Francesco Saverio Ambesi-Impiombato; Francesco Curcio
Journal:  Int J Mol Sci       Date:  2017-04-26       Impact factor: 5.923

3.  Exploiting GRK2 Inhibition as a Therapeutic Option in Experimental Cancer Treatment: Role of p53-Induced Mitochondrial Apoptosis.

Authors:  Jessica Gambardella; Antonella Fiordelisi; Gaetano Santulli; Michele Ciccarelli; Federica Andrea Cerasuolo; Marina Sala; Eduardo Sommella; Pietro Campiglia; Maddalena Illario; Guido Iaccarino; Daniela Sorriento
Journal:  Cancers (Basel)       Date:  2020-11-26       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.